UBS Group
YCBD icon

UBS Group’s cbdMD YCBD Stock Holding History

UBS Group’s Portfolio YCBD Stock Details YCBD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$122K Buy
164,643
+154,492
+1,522% +$132K ﹤0.01% 6904
2025
Q4 		$13.7K Buy
10,151
+10,141
+101,410% +$10.2K ﹤0.01% 8041
2025
Q3 		$12 Sell
10
-1,584
-99% -$1.3K ﹤0.01% 10177
2025
Q2 		$1.42K Sell
1,594
-3,076
-66% -$4.04K ﹤0.01% 9622
2025
Q1 		$8.59K Buy
+4,670
New +$16.4K ﹤0.01% 8744
2024
Q4 		– Sell
-397
Closed -$1.49K – 10489
2024
Q3 		$1.49K Sell
397
-2,461
-86% -$10.7K ﹤0.01% 8624
2024
Q2 		$13.5K Buy
2,858
+1,041
+57% +$6.49K ﹤0.01% 7549
2024
Q1 		$13.5K Buy
+1,817
New +$11.2K ﹤0.01% 7098
2023
Q4 		– Sell
-13
Closed -$105 – 9966
2023
Q3 		$105 Buy
13
+11
+550% +$113 ﹤0.01% 8873
2023
Q2 		$17 Buy
2
+1
+100% +$26 ﹤0.01% 8704
2023
Q1 		$98 Hold
1
– – ﹤0.01% 9249
2022
Q4 		$115 Sell
1
-37
-97% -$3.73K ﹤0.01% 10387
2022
Q3 		$3K Sell
38
-60
-61% -$8.61K ﹤0.01% 9597
2022
Q2 		$15K Buy
98
+45
+85% +$10.7K ﹤0.01% 7321
2022
Q1 		$20K Sell
53
-113
-68% -$38.2K ﹤0.01% 7462
2021
Q4 		$65K Buy
166
+148
+822% +$86K ﹤0.01% 6692
2021
Q3 		$13K Sell
18
-42
-70% -$35.2K ﹤0.01% 7696
2021
Q2 		$62K Sell
60
-9
-13% -$10.8K ﹤0.01% 6245
2021
Q1 		$103K Buy
69
+62
+886% +$90.1K ﹤0.01% 5942
2020
Q4 		$7K Sell
7
-14
-67% -$12.7K ﹤0.01% 7714
2020
Q3 		$15K Buy
21
+17
+425% +$16.2K ﹤0.01% 6540
2020
Q2 		$3K Sell
4
-49
-92% -$22K ﹤0.01% 7564
2020
Q1 		$17K Buy
53
+9
+20% +$3.55K ﹤0.01% 6599
2019
Q4 		$36K Buy
44
+43
+4,300% +$51.6K ﹤0.01% 6546
2019
Q3 		$2K Buy
+1
New +$1.6K ﹤0.01% 7757
2019
Q2 		– Sell
-5
Closed -$7K – 8205
2019
Q1 		$7K Buy
+5
New +$7.86K ﹤0.01% 7025
2018
Q3 		– Sell
-5
Closed -$7K – 8314
2018
Q2 		$7K Buy
5
+3
+150% +$4.93K ﹤0.01% 7353
2018
Q1 		$3K Sell
2
-9
-82% -$14K ﹤0.01% 7449
2017
Q4 		$17K Buy
+11
New +$18.9K ﹤0.01% 6685

Other funds holding YCBD

WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group's YCBD Position: Q1 2026 in Review

UBS Group increased its cbdMD (YCBD) stake by 1,522% in Q1 2026, buying an estimated $132K and bringing the position to 164,643 shares worth $122K. The position accounts for ﹤0.01% of the portfolio, ranked #6904.

UBS Group first reported a position in YCBD in Q4 2017 and has held it in 29 quarters since. 25 funds tracked by Wall St. Rank hold YCBD as of Q1 2026.

  • UBS Group held 164,643 shares of cbdMD worth $122K as of Q1 2026.
  • UBS Group bought 154,492 cbdMD shares in Q1 2026, an estimated $132K.
  • cbdMD made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6904 holding.
  • UBS Group first reported a position in cbdMD in Q4 2017 and has held it in 29 quarters since.
  • 25 funds tracked by Wall St. Rank held cbdMD as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.